Are investors shorting InfuSystem?

InfuSystem saw a decline in short interest in March. As of March 31st, there was short interest totaling 233,700 shares, a decline of 11.1% from the March 15th total of 262,900 shares. Based on an average daily trading volume, of 46,200 shares, the days-to-cover ratio is currently 5.1 days. Currently, 1.3% of the shares of the company are short sold. View InfuSystem's Short Interest .

How were InfuSystem's earnings last quarter?

InfuSystem Holdings, Inc. (NYSEAMERICAN:INFU) issued its quarterly earnings data on Monday, November, 15th. The medical instruments supplier reported ($0.02) earnings per share for the quarter, missing analysts' consensus estimates of $0.03 by $0.05. The medical instruments supplier earned $26.57 million during the quarter, compared to the consensus estimate of $28 million. InfuSystem had a net margin of 0.69% and a trailing twelve-month return on equity of 1.73%.

What other stocks do shareholders of InfuSystem own?

Based on aggregate information from My MarketBeat watchlists, some companies that other InfuSystem investors own include Macquarie Infrastructure (MIC) , Second Sight Medical Products (EYES) , Otelco (OTEL) , Pershing Gold (PGLC) , Palatin Technologies (PTN) , AgroFresh Solutions (AGFS) , Advanced Micro Devices (AMD) and Digital Turbine (APPS) .

How do I buy shares of InfuSystem?

Shares of INFU stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

NYSEAMERICAN:INFU

InfuSystem (INFU) Stock Price, News & Analysis

→ Your Next Portfolio Star: Revealing 2024's Top Stock Pick (From Darwin) (Ad)

Free INFU Stock Alerts

$7.80

-0.07 (-0.89%)

(As of 04/18/2024 ET)

Compare

Today's Range: $7.81
▼
$7.95
50-Day Range: N/A
52-Week Range: $7.75
▼
$11.44

Volume: 35,739 shs
Average Volume: 49,664 shs
Market Capitalization: $165.93 million

P/E Ratio: 260.25
Dividend Yield: N/A
Price Target: N/A

Get InfuSystem alerts:

InfuSystem MarketRank™ Stock Analysis

Analyst Rating: N/A
Upside/Downside: N/A
Short Interest: Healthy
1.26% of Float Sold Short
Dividend Strength: N/A
Sustainability: -1.20
Upright™ Environmental Score
News Sentiment: 0.31
Based on 2 Articles This Week
Insider Trading: N/A
Proj. Earnings Growth: N/A

Overall MarketRank^™

New Rank-Based ScoringMarketRank^™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

1.53 out of 5 stars

N/A

Analyst's Opinion

Consensus Rating
There is not enough analysis data for InfuSystem.

4.0

Short Interest

Percentage of Shares Shorted
1.26% of the float of InfuSystem has been sold short.
Short Interest Ratio / Days to Cover
InfuSystem has a short interest ratio ("days to cover") of 5.1.
Change versus previous month
Short interest in InfuSystem has recently decreased by 11.11%, indicating that investor sentiment is improving significantly.

0.0

Dividend Strength

Dividend Yield
InfuSystem does not currently pay a dividend.
Dividend Growth
InfuSystem does not have a long track record of dividend growth.

4.0

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
InfuSystem has received a 55.56% net impact score from Upright. The largest positive contribution comes from its "Physical diseases" impact, which is mostly driven by its "Intravenous therapy equipment", "Medical dispensing pumps", and "Catheters" products. See details.
Environmental Sustainability
The Environmental Impact score for InfuSystem is -1.20.

3.0

News and Social Media Coverage

News Sentiment
InfuSystem has a news sentiment score of 0.31. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.53 average news sentiment score of Medical companies.
News Coverage This Week
MarketBeat has tracked 2 news articles for InfuSystem this week, compared to 1 article on an average week.
Search Interest
1 people have searched for INFU on MarketBeat in the last 30 days.
MarketBeat Follows
1 people have added InfuSystem to their MarketBeat watchlist in the last 30 days.

2.5

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, InfuSystem insiders have not sold or bought any company stock.
Percentage Held by Insiders
18.50% of the stock of InfuSystem is held by insiders. A high percentage of insider ownership can be a sign of company health.
Percentage Held by Institutions
71.13% of the stock of InfuSystem is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

0.0

Earnings and Valuation

Price to Earnings Ratio vs. the Market
The P/E ratio of InfuSystem is 260.25, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 136.92.
Price to Earnings Ratio vs. Sector
The P/E ratio of InfuSystem is 260.25, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 191.64.
Price to Book Value per Share Ratio
InfuSystem has a P/B Ratio of 3.16. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

Ad Insiders Exposed

This consistently signaled gains of 453%... 610%... and even 1036%...

It doesn’t happen often, but occasionally, something completely unique comes across my radar. In this case, I’m talking about legal “Insider Trading”. Traders who have consistently signaled 453% … 610% .. and even 1036%... gains. And until now they have been doing it completely under the radar. In an upcoming interview I am revealing the strategy behind this gold-mine and how you can piggy back their every trade.

About InfuSystem Stock (NYSEAMERICAN:INFU)

InfuSystem Holdings, Inc., through its subsidiaries, provides infusion pumps, and related products and services in the United States and Canada. The company operates in two segments, Integrated Therapy Services (ITS) and Durable Medical Equipment Services (DME Services). It supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states. The company also sells, rents, and leases new and pre-owned pole-mounted and ambulatory infusion pumps, and other durable medical equipment; sells treatment-related consumables; and provides biomedical recertification, maintenance, and repair services for oncology practices, as well as other healthcare site settings comprising hospitals, home care and home infusion providers, skilled nursing and acute care facilities, pain centers, and others. In addition, it offers local and field-based customer support, as well as operates pump service and repair centers. The company was incorporated in 2005 and is headquartered in Rochester Hills, Michigan.

INFU Stock Price History

30 days | 90 days | 365 days | Advanced Chart

INFU Stock News Headlines

April 17, 2024 | americanbankingnews.com

InfuSystem (NYSEAMERICAN:INFU) Raised to "Strong-Buy" at StockNews.com

April 13, 2024 | americanbankingnews.com

InfuSystem (NYSEAMERICAN:INFU) Rating Increased to Strong-Buy at StockNews.com

April 19, 2024 | DTI (Ad)

This company has increased its dividend every year for 54 years

There are three basic steps to building the Ultimate Dividend Portfolio. Step #1 is to Get The High Yields! So an index fund like the SPY, paying only 1.5% a year, isn’t going to cut it. But a company like Altria Group (MO) will.

April 10, 2024 | americanbankingnews.com

InfuSystem (NYSEAMERICAN:INFU) Stock Price Crosses Above Two Hundred Day Moving Average of $0.00

April 3, 2024 | businesswire.com

InfuSystem Receives Notice from NYSE American Regarding Late Filing of Annual Report on Form 10-K

April 1, 2024 | markets.businessinsider.com

Analysts Offer Insights on Healthcare Companies: Forian (FORA), Achieve Life Sciences (ACHV) and P3 Health Partners (PIII)

March 26, 2024 | investorplace.com

Double Down: 7 Beaten-Down Growth Stocks to Buy Hand Over Fist

March 20, 2024 | money.usnews.com

InfuSystem Holdings Inc

April 19, 2024 | DTI (Ad)

This company has increased its dividend every year for 54 years

March 15, 2024 | markets.businessinsider.com

Analysts Are Bullish on Top Healthcare Stocks: InfuSystem Holdings, Inc. (INFU), Aquestive Therapeutics (AQST)

March 15, 2024 | finance.yahoo.com

InfuSystem Holdings, Inc. (AMEX:INFU) Q4 2023 Earnings Call Transcript

March 15, 2024 | finance.yahoo.com

Q4 2023 InfuSystem Holdings Inc Earnings Call

March 14, 2024 | msn.com

InfuSystem GAAP EPS of $0.00 in-line, revenue of $31.77M beats by $1.77M

March 14, 2024 | finance.yahoo.com

InfuSystem Announces Operational and Financial Results for Fourth Quarter and Full Year 2023

March 14, 2024 | finance.yahoo.com

InfuSystems Holdings Inc (INFU) Reports Solid Growth in 2023 with Record Net Revenues and ...

March 8, 2024 | businesswire.com

InfuSystem to Report Fourth Quarter and Full Year 2023 Financial Results on March 14, 2024

February 29, 2024 | seekingalpha.com

InfuSystem Holdings: 2024 Will Be A Year Of Monetization

February 1, 2024 | markets.businessinsider.com

Analysts’ Top Healthcare Picks: EDAP TMS (EDAP), DermTech (DMTK)

January 10, 2024 | markets.businessinsider.com

Analysts’ Top Consumer Cyclical Picks: Carbon Revolution (CREV), Kura Sushi USA (KRUS)

January 9, 2024 | markets.businessinsider.com

Analysts Are Bullish on Top Healthcare Stocks: BioLife Solutions (BLFS), Dynavax (DVAX)

January 2, 2024 | markets.businessinsider.com

Analysts Offer Insights on Healthcare Companies: Streamline Health Solutions (STRM), MiMedx Group (MDXG) and Integra Lifesciences (IART)

November 11, 2023 | markets.businessinsider.com

Analysts Offer Insights on Healthcare Companies: Sensus Healthcare (SRTS), BioLife Solutions (BLFS) and Xeris Pharmaceuticals (XERS)

November 7, 2023 | msn.com

InfuSystem GAAP EPS of $0.03, revenue of $31.9M

November 6, 2023 | markets.businessinsider.com

Analysts’ Top Healthcare Picks: ModivCare (MODV), Clearside Biomedical (CLSD)

November 6, 2023 | msn.com

InfuSystem Q3 2023 Earnings Preview

November 3, 2023 | markets.businessinsider.com

Analysts Offer Insights on Healthcare Companies: Tandem Diabetes Care (TNDM), BioMarin Pharmaceutical (BMRN) and Atricure (ATRC)

October 31, 2023 | finance.yahoo.com

InfuSystem to Report Third Quarter 2023 Financial Results on November 7, 2023

See More Headlines

Receive INFU Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for InfuSystem and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 11/15/2021
Today: 4/19/2024
Fiscal Year End: 12/31/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NYSEAMERICAN
Sector: Medical
Industry: Surgical & medical instruments
Sub-Industry: N/A
Current Symbol: NYSEAMERICAN:INFU
Previous Symbol: NYSE:INFU
CUSIP: N/A
CIK: 1337013
Web: ir.infusystem.com
Phone: (124) 291-1210
Fax: 800-455-4338
Employees: 420
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): $0.03
Trailing P/E Ratio: 260.25
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $870,000.00
Net Margins: 0.69%
Pretax Margin: 1.47%
Return on Equity: 1.73%
Return on Assets: 0.85%

Debt

Debt-to-Equity Ratio: 0.56
Current Ratio: 1.95
Quick Ratio: 1.54

Sales & Book Value

Annual Sales: $125.79 million
Price / Sales: 1.32
Cash Flow: $0.63 per share
Price / Cash Flow: 12.35
Book Value: $2.47 per share
Price / Book: 3.16

Miscellaneous

Outstanding Shares: 21,260,000
Free Float: 17,331,000
Market Cap: $165.93 million
Optionable: Not Optionable
Beta: 1.24

The Best High-Yield Dividend Stocks for 2024

Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.

Get This Free Report

Key Executives

Mr. Richard A. DiIorio (Age 49)
CEO & Director
Comp: $806.26k
Ms. Carrie A. Lachance B.S.N. (Age 47)
M.B.A., R.N., President, COO & Director
Comp: $473.54k
Mr. Barry G. Steele (Age 53)
Executive VP & CFO
Comp: $303.33k
Mr. Addam Chupa (Age 45)
Executive VP & Chief Information Officer
Jerod Funke
Executive VP & Chief HR Officer
Jeanie Latz
Corporate Secretary

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions

INFU Stock Analysis - Frequently Asked Questions

Are investors shorting InfuSystem?: InfuSystem saw a decline in short interest in March. As of March 31st, there was short interest totaling 233,700 shares, a decline of 11.1% from the March 15th total of 262,900 shares. Based on an average daily trading volume, of 46,200 shares, the days-to-cover ratio is currently 5.1 days. Currently, 1.3% of the shares of the company are short sold.
View InfuSystem's Short Interest.
How were InfuSystem's earnings last quarter?: InfuSystem Holdings, Inc. (NYSEAMERICAN:INFU) issued its quarterly earnings data on Monday, November, 15th. The medical instruments supplier reported ($0.02) earnings per share for the quarter, missing analysts' consensus estimates of $0.03 by $0.05. The medical instruments supplier earned $26.57 million during the quarter, compared to the consensus estimate of $28 million. InfuSystem had a net margin of 0.69% and a trailing twelve-month return on equity of 1.73%.
What other stocks do shareholders of InfuSystem own?: Based on aggregate information from My MarketBeat watchlists, some companies that other InfuSystem investors own include Macquarie Infrastructure (MIC), Second Sight Medical Products (EYES), Otelco (OTEL), Pershing Gold (PGLC), Palatin Technologies (PTN), AgroFresh Solutions (AGFS), Advanced Micro Devices (AMD) and Digital Turbine (APPS).
How do I buy shares of InfuSystem?: Shares of INFU stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NYSEAMERICAN:INFU) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

InfuSystem (INFU) Stock Price, News & Analysis

InfuSystem MarketRank™ Stock Analysis

Overall MarketRank™